November 2017 FDA Recall Drug by Glenmark Pharmaceuticals Inc., Usa
D-0336-2018 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Glenmark Pharmaceuticals Inc., Usa on November 20, 2017 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in Product was distributed throughout the United States. and the recall is currently terminated.

Recall Number: D-0336-2018

Reason for Recall
CGMP Deviations: Market complaints related to "gritty texture".
Initiated
11-20-2017
Reported
02-07-2018
Quantity
5136 tubes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Glenmark Pharmaceuticals Inc., USA
Product was distributed throughout the United States.
Glenmark Mometasone Furoate Cream, USP, 0.1%, 45 g Rx Only Manufactured by: Glenmark Pharmaceuticals Ltd. Village Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 NDC 68462019255 UPC 3684620192559

Batch or Lot Expiration Information

Batch# Batch Number: 05170598; Exp. 03/19